What's new

Covid origins investigation: US House of Representatives holds first hearing

Sirris

First Class Captain
Joined
Jun 14, 2017
Runs
4,310
Post of the Week
3
As a exact opposite to the conspiracy theory thread let's post the latest studies and research based findings on covid-19 which could be of benefit for the average person too.

Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections Among the General Population




https://pubmed.ncbi.nlm.nih.gov/18612429/

New study suggests wearing any kind of mask is beneficial over wearing no mask at all.

Start making your own home mask everyone and leave the professional masks for health workers. Look up YouTube tutorials, for the most lazy I suggest wearing a small towel cloth when going outside.

Tailor shops should be encouraged to produce masks financially supported.

Also don't use the same mask daily nor throw it away. Hang the mask at the night and after couple of days you can reuse it since the virus can not survive longer than a couple days. Make sure you don't have touch the front part of the mask which is exposed to the air and wash your hands afterwards.
 
How about washing the mask and wearing it over and over? Does it work?

I have 3-4 masks (bought these more than 1 year ago). These are not N95 masks. These are regular surgical masks.
 
How about washing the mask and wearing it over and over? Does it work?

I have 3-4 masks (bought these more than 1 year ago). These are not N95 masks. These are regular surgical masks.

Washing it is most likely going to cause it to break and tear.

Applying a healthy dose of disinfectant spray may work.
 
Covid-19 fatality is likely overestimated


The final case fatality rate (CFR) from SARS-CoV-2, the virus
that causes covid-19, will likely be lower than those initially
reported.

Previous reviews of H1N1 and SARS show the
systematic inflation of early mortality estimates. Early
estimates of H1N1’s mortality were susceptible to uncertainty
about asymptomatic and subclinical infections, heterogeneity
in approaches to diagnostic testing, and biases in confounding,
selection, detection, reporting, and so on.These biases are
difficult to overcome early in a pandemic.

We read Xu and colleagues’ report of 62 cases of covid-19
outside of Wuhan, China, with interest, as no patients died in
the study period. Compared with a report of the 72 314 cases
throughout China, the marked differences in outcomes from
Hubei (the province of which Wuhan is the capital) compared
with all other provinces are worth a brief discussion.

The CFR in China (through 11 February) is reported as 2.3%.1 5
The CFR among the initial Wuhan cohort was reported as 4.3%,
with a rate of 2.9% in Hubei province.1 5 But outside Hubei the
CFR has been 0.4%. Deaths occurred only in cases deemed
“critical.” Importantly, the CFR from these reports is from
infected, syndromic people presenting to healthcare facilities,
with higher CFRs among older patients in hospital (8%-14.8%
in the Wuhan cohort).

As accessibility and availability of testing for the novel
coronavirus increases, the measured CFR will continue to drop,
especially as subclinical and mild cases are identified.
Alternatively, the CFR might not fall as much as in previous
epidemics and pandemics, given the prolonged disease course
of covid-19 or if mitigation measures or hospital resources prove
inadequate.

As with other pandemics, the final CFR for covid-19 will be
determined after the pandemic and should not distract from the
importance of aggressive, early mitigation to minimise spread
of infection

https://sci-hub.tw/https://www.bmj.com/content/368/bmj.m1113
 
Learn from the chinese DIY mask at home


5e46a0f0a310128206525d24.jpeg


http://www.chinadaily.com.cn/a/202002/14/WS5e46a0f0a310128217277aff.html


Besides watching netflix all day get productive guys and make some masks
 
Start making your own home mask everyone and leave the professional masks for health workers.

Why aren't health workers being provided equipment to do their jobs? Masks and gloves are surely right up there in terms of important equipment to provide care?
 
Why aren't health workers being provided equipment to do their jobs? Masks and gloves are surely right up there in terms of important equipment to provide care?

Usually a doctor wouldn't require a facial mask to check a regular patient. Now due to the situation everyone could be a potential carrier of the virus and is a suspect. Last week I went to an eye specialist and all the medical staff from receptionist to the doctor were wearing gloves and masks. Not a normal sight. Therefore a rapid worldwide increase in demand has led to local shortage. On top of that most countries rely on China to supply them and China has been busy with providing it's own staff for the last few months.

Many European countries have enough supply for now the question is will they run out of them if the rate of infection and new patients needed treatment keeps on increasing while many people are hoarding masks at home.

Poor countries like Pakistan always had bad and insufficient medical facilities. Corona only highlighted those weakness.
 
Investigational COVID-19 Convalescent Plasma - Emergency INDs



One investigational treatment being explored for COVID-19 involves the use of convalescent plasma collected from recovered COVID-19 patients. It is possible that convalescent plasma that contains antibodies to SARS-CoV-2 (the virus that causes COVID-19) might be effective against the infection. Use of convalescent plasma has been studied in outbreaks of other respiratory infections, including the 2009-2010 H1N1 influenza virus pandemic, 2003 SARS-CoV-1 epidemic, and the 2012 MERS-CoV epidemic. Although promising, convalescent plasma has not been shown to be effective in every disease studied. It is therefore important to determine through clinical trials, before routinely administering convalescent plasma to patients with COVID-19, that it is safe and effective to do so. Investigators wishing to study the use of convalescent plasma are encouraged to submit requests to FDA for investigational use under the traditional IND regulatory pathway (21 CFR 312).

https://www.fda.gov/vaccines-blood-...l-covid-19-convalescent-plasma-emergency-inds

@mogul
 
Senegal: 10-minute coronavirus test may be on its way - for $1

Dakar, Senegal - Researchers this week began validation trials on a COVID-19 diagnostic test that can be done at home and produce results in as little as 10 minutes - all for $1.

The plan is to dually manufacture the tests in Senegal and the United Kingdom and if the validation testing meets regulatory standards, they could be distributed across Africa as early as June.

"Our focus is to provide tests to the African continent," Amadou Sall, director of the Pasteur Institute in Dakar, told Al Jazeera.

Sall and his team of researchers in the Senegalese capital, which have previously worked on vaccines for yellow fever and dengue, developed the prototype for the diagnostic test in partnership with Mologic, a British biotech company founded by the inventor of the Clearblue pregnancy test.

Once ready, the tests will be produced in the UK and at a new Dakar-based facility managed by DiaTropix, a subsidiary of the Pasteur Institute that focuses on infectious disease testing.

According to Sall, the Dakar site will have an initial capacity to produce up to four million tests annually. The developers are also in early-stage talks for local manufacturing sites to be set up in other parts of the continent.

"When COVID-19 hit, we knew from the beginning that Africa would be disproportionally affected," Joe Fitchett, the medical director of Mologic told Al Jazeera. "With a test like this, you can detect [the virus] very quickly on any part of the continent and then avoid transmission."

To detect as many people as possible, Fitchett says the test will be sold at cost-price - which is approximately $1 - thanks to grant support from the UK government and the Bill and Melinda Gates Foundation.

"The point is to keep it to the bottom," Fitchett said, adding they would work with suppliers to keep the price as low as possible.

Game-changer?

COVID-19, the highly infectious respiratory disease caused by the new coronavirus, has no vaccine or known treatment regiment.

Until a vaccine is ready, widespread testing is seen as one of the most important strategies used to "flatten the curve" - slowing the spread of the contagion in an attempt to prevent already stretched healthcare systems from being overrun.

Earlier this month, World Health Organization chief Tedros Adhanom Ghebreyesus urged countries to build up their testing capacity to curb the spread of the coronavirus pandemic, calling them to "test, test, test".

"The most effective way to prevent infections and save lives is breaking the chains of transmission. And to do that, you must test and isolate," he told reporters in Geneva. "You cannot fight a fire blindfolded. And we cannot stop this pandemic if we don't know who is infected."

With tests at advanced, centralised laboratories still costly and taking hours to complete, scores of companies worldwide are working to develop rapid, easy-to-use kits and then distribute them widely - but questions remain over their accuracy.

Price and availability, however, are not the only barriers to widespread use. By developing a test that can be done at home without any need for electricity, the researchers in Senegal say it can be of particular use in rural communities where power is limited and laboratories are near inaccessible.

Their test can be done in two different ways - using saliva or blood. Those with an active infection would use a saliva swab to detect the new coronavirus, while those with a previously undetected case would use an at-home finger ***** test to check for coronavirus antibodies.

There are currently more than 2,800 confirmed cases in 45 of the continent's 54 countries. While that is still significantly lower than the current epicentre in Europe, some analysts fear Africa is on course to follow a similar trajectory.

Such a scenario would spell disaster in a continent that accounts for 1 percent of global health expenditure but carries 23 percent of the disease burden. Weaker health systems, poor sanitation and water shortages are just some of the additional challenges that would make it harder to fight the virus.

The Africa Centers for Disease Control and Prevention (CDC) has significantly ramped up its prevention strategy in recent weeks, training labs in 43 countries, a swift increase from only two countries that were able to test for the disease in February. The Africa CDC has also been providing 1,000 test kits to any country with cases. Billionaire Jack Ma donated an additional 1.1 million test kits. But that still is only a drop in the bucket compared with what will be needed.

"In times like these, it's difficult for African governments to purchase tests which are also cheaper and cost effective," Prashant Yadav, a global supply chain analyst at the Center for Global Health, told Al Jazeera.

That is why he says the continent having a test of its own could be a game-changer. "You're giving people on the continent access to a new test which very other few groups have had access to," Yadav said.

Independent assessment critical

Prototypes for the diagnostic test are now being assessed by two laboratories in the UK; the Liverpool School of Tropical Medicine and St. Georges University London. Additional tests have been sent for independent assessment at labs around the world, including Senegal, Spain, China, Malaysia and Brazil.

The development of the prototype comes less than three weeks after Mologic was awarded one million British pounds ($1.2m) from the UK government as part of a 46 million British pounds ($56m) fund for international coronavirus prevention and research. That is rapid speed for a diagnostic test, which typically takes years to develop.

Fitchett credited Mologic’s partnership with the Pasteur Institute in Dakar - which has previously worked on vaccines for yellow fever and dengue - for speeding up the process.

At the same time, he emphasied the importance of following all proper validation procedures.

"Independent assessment is so critical, which is why we're working with top labs on every continent," Fitchett said. "It's not in our interest to send something out that’s no good."

Authorities have been cracking down on a rise in fake testing kits being distributed, often sold at a high markup, as people around the world search desperately to get tested amidst shortages.

https://www.aljazeera.com/news/2020/03/senegal-10-minute-coronavirus-test-1-200327053901231.html
 
This is an absolute idiosyncratic beast.

We can't say who will get it and who won't. We can't say how each patient will respond and how will it manifest in different patients. We don't know the effects of different treatment option.

From etiology to symptoms to treatment, this is an absolute idiosyncratic beast.

Till now, Only disease I considered idiosyncratic in behaviour as broadly as this, was GB Syndrome. But for me, this now replaces GBS.
 
Visiting this and the vaccine thread everyday to get some hope absolutely nothing!
 
The problem with passive immunity is that it leaves the patient susceptible to re-infection, which in the current climate would not be unlikely
 
I wish there was a time machine that allowed us to go in the future to bring back a vacine.
 
The woman behind India's first coronavirus testing kit

Virologist delivered kit, then her baby

This could be a game changer with test kit costing about 800rs and delivers results in less than 3 hours

==

India has been criticised for its poor record of testing people in the battle against coronavirus. That, however, is set to change, thanks in large part to the efforts of one virologist, who delivered on a working test kit, just hours before delivering her baby .

On Thursday, the first made-in-India coronavirus testing kits reached the market, raising hopes of an increase in screening of patients with flu symptoms to confirm or rule out the Covid-19 infection.

Mylab Discovery, in the western city of Pune, became the first Indian firm to get full approval to make and sell testing kits. It shipped the first batch of 150 to diagnostic labs in Pune, Mumbai, Delhi, Goa and Bengaluru (Bangalore) this week.

"Our manufacturing unit... is working through the weekend and the next batch will be sent out on Monday," Dr Gautam Wankhede, Mylab's director for medical affairs, told the BBC on Friday.

The molecular diagnostic company, which also makes testing kits for HIV and Hepatitis B and C, and other diseases, says it can supply up to 100,000 Covid-19 testing kits a week and can produce up to 200,000 if needed.

Each Mylab kit can test 100 samples and costs 1,200 rupees ($16; £13) - that's about a quarter of the 4,500 rupees that India pays to import Covid-19 testing kits from abroad.

"Our kit gives the diagnosis in two and a half hours while the imported testing kits take six-seven hours," says virologist Minal Dakhave Bhosale, Mylab's research and development chief.

Ms Bhosale, who headed the team that designed the coronavirus testing kit called Patho Detect, said it was done "in record time" - six weeks instead of three or four months.

And the scientist was battling with her own deadline too. Last week she gave birth to a baby girl - and only began work on the programme in February, just days after leaving hospital with a pregnancy complication.

"It was an emergency, so I took this on as a challenge. I have to serve my nation," she says, adding that her team of 10 worked "very hard" to make the project a success.

In the end, she submitted the kit for evaluation by the National Institute of Virology (NIV) on 18 March, just a day before delivering her daughter.

That same evening, just an hour before she was taken to hospital ahead of her Caesarean, she submitted the proposal to the Indian FDA and the drugs control authority CDSCO for commercial approval.

"We were running against time," says Dr Wankhede. "Our reputation was at stake, we had to get everything right on the first go, and Minal was leading our efforts from the front."

Before submitting the kits for evaluation, the team had to check and re-check all the parameters to ensure its results that were precise, and accurate.

"If you carry out 10 tests on the same sample, all 10 results should be same," said Ms Bhosale. "And we achieved that. Our kit was perfect."

Why is India testing so little?

The government-run Indian Council for Medical Research (ICMR), under which NIV operates, agreed. It said Mylab was the only Indian company to achieve 100% results.

'Gaping holes in Indian health system'

India has been criticised for not testing enough. It has one of the lowest rates in the world, with just 6.8 tests per million.

Initially, India insisted on testing only those who had travelled to high-risk countries or had come in contact with an infected person or health workers treating coronavirus patients. It later said that anyone admitted to hospital with severe respiratory distress should also be tested.

But with the circle of infection widening daily, the numbers are expected to grow hugely.

In the past few days, India has scaled up testing. Initially, only the state labs were allowed to test for coronavirus, but permission has now been extended to several private labs too.

And on Thursday, India also gave approvals to 15 private companies to commercially sell diagnostic kits based on licences they have obtained in the US, European Union and some other countries.

Dr Wankhede says with the number of suppliers and labs increasing every day, the testing will go up exponentially.

Increased testing would be a huge help, but experts say India has gaping holes in its health infrastructure that need to be plugged urgently to deal with the growing threat of coronavirus.

"South Korea - that's so tiny - has 650 labs testing for the coronavirus, how many do we have?" asks Sujatha Rao, former federal health secretary.

India has only 118 government laboratories and officials say 50 private labs will also be roped in.

For a population of 1.3 billion, that is far from adequate.

"India will have to identify many more labs, then the testing kits have to reach there, and technicians have to be trained. And getting the infrastructure ramped up will take time," Ms Rao says.

And once the test results start coming in and if a large number of people test positive and require hospitalisation, India will find it difficult to cope.

"You know the state of the healthcare facilities in the country? They are all bunched up in urban areas, there's very little facility in rural India. That will be a big challenge," she says.




https://www.bbc.com/news/world-asia-india-52064427
 
Last edited by a moderator:
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">BREAKING: We’re launching a test that can detect COVID-19 in as little as 5 minutes—bringing rapid testing to the frontlines. <a href="https://t.co/LqnRpPpqMM">https://t.co/LqnRpPpqMM</a> <a href="https://t.co/W8jyN2az8G">pic.twitter.com/W8jyN2az8G</a></p>— Abbott (@AbbottNews) <a href="https://twitter.com/AbbottNews/status/1243680163054915584?ref_src=twsrc%5Etfw">March 27, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
I wish there was a time machine that allowed us to go in the future to bring back a vacine.

I would much rather go back in time and close those wild animal markets in China.
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">BREAKING: We’re launching a test that can detect COVID-19 in as little as 5 minutes—bringing rapid testing to the frontlines. <a href="https://t.co/LqnRpPpqMM">https://t.co/LqnRpPpqMM</a> <a href="https://t.co/W8jyN2az8G">pic.twitter.com/W8jyN2az8G</a></p>— Abbott (@AbbottNews) <a href="https://twitter.com/AbbottNews/status/1243680163054915584?ref_src=twsrc%5Etfw">March 27, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
That will be great.
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">Dyson has designed and built an entirely new ventilator, called the "CoVent," since founder James Dyson received a call 10 days ago from UK Prime Minister Boris Johnson. "This new device can be manufactured quickly, efficiently and at volume," he said <a href="https://t.co/ZtwxAWBP0R">https://t.co/ZtwxAWBP0R</a></p>— CNN (@CNN) <a href="https://twitter.com/CNN/status/1244218009742462976?ref_src=twsrc%5Etfw">March 29, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">Chinese scientists have developed a new weapon to combat the <a href="https://twitter.com/hashtag/coronavirus?src=hash&ref_src=twsrc%5Etfw">#coronavirus</a>. They say they have found a nanomaterial that can absorb and deactivate the virus with 96.5-99.9% efficiency. <a href="https://t.co/ESFUOoTuIX">pic.twitter.com/ESFUOoTuIX</a></p>— Global Times (@globaltimesnews) <a href="https://twitter.com/globaltimesnews/status/1244244793393217536?ref_src=twsrc%5Etfw">March 29, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">MIT has Posted Free Plans Online for an Emergency Ventilator That Can Be Built for $100.<a href="https://t.co/OhQjFhZ5kC">https://t.co/OhQjFhZ5kC</a></p>— Sinan Aral (@sinanaral) <a href="https://twitter.com/sinanaral/status/1244107247959056384?ref_src=twsrc%5Etfw">March 29, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
Chinese scientists develop a new "weapon" to combat the coronavirus

<blockquote class="twitter-tweet"><p lang="en" dir="ltr">Chinese scientists have developed a new weapon to combat the <a href="https://twitter.com/hashtag/coronavirus?src=hash&ref_src=twsrc%5Etfw">#coronavirus</a>. They say they have found a nanomaterial that can absorb and deactivate the virus with 96.5-99.9% efficiency. <a href="https://t.co/ESFUOoTuIX">pic.twitter.com/ESFUOoTuIX</a></p>— Global Times (@globaltimesnews) <a href="https://twitter.com/globaltimesnews/status/1244244793393217536?ref_src=twsrc%5Etfw">March 29, 2020</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

Whether they have developed it or not, the choice of words in this tweet is interesting
 
96 to 99 is pretty massive gap and can severely affect how useful it is. Does anyone have the link to the actual study behind this?
 
Half of those capsules will be defective duds.
 
Don’t go near it unless approved by the US FDA or EU regulators

Exactly

We are at least 12-18 months away from a commercial vaccine, considering there is one after all these efforts.

Humans need to put their planning and investments into making lifestyle changes and boosting the healthcare infrastructure.

COVID19 would be history soon. We will be fighting some other bug in the future
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">FDA authorizes use of new two-minute test kit for coronavirus <a href="https://t.co/bvFl6xAvtI">https://t.co/bvFl6xAvtI</a> <a href="https://t.co/e5SpETqvbb">pic.twitter.com/e5SpETqvbb</a></p>— Reuters (@Reuters) <a href="https://twitter.com/Reuters/status/1245004393721856007?ref_src=twsrc%5Etfw">March 31, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
Strain of coronavirus prevalent in Pakistan different from Chinese one: Dr Atta

Former chairman of the Higher Education Commission (HEC) Prof Dr Atta-ur-Rehman said on Monday that new research suggests that the strain of coronavirus spreading in Pakistan is different than the one that originated in China.

The respected Pakistani scientist, who specialises in organic chemistry, said the Chinese strain of the coronavirus has different chromosomes than the Pakistani variant.

"The Chinese strain has more potent chromosomes than the Pakistani strain of the coronavirus," he said in a conversation on Geo News.

The scientist said the revelation came during recent research carried out at the Jamil-ur-Rahman Center for Genome Research at the University of Karachi.

A global race is on to better understand the novel coronavirus. Scientists and virologists around the world have been racing against the clock to develop a vaccine or cure before the virus overwhelms health systems and cripples the global economy.

Meanwhile, China seems to have bounced back from the overwhelming force of the coronavirus onslaught, which began in late December. The original epicentre of the virus, Hubei province's Wuhan city, has seen a partial removal of lockdown last week and things are slowly returning to normal.

On the other hand, Pakistan is just beginning to feel the impact of the virus's outbreak, which has claimed 19 lives so far and infected more than 1,600.

Chinese authorities have been helping Pakistan attempt to overcome the challenge presented by the pandemic by lending medical aid and doctors who are sharing their expertise.

On March 28, Chinese flights carrying a third installment of medical supplies and a team of doctors had arrived in Pakistan.

Meanwhile, the world is still struggling to contain the disease, with the epicentre now shifting to the US from Europe.

More than 33,000 deaths have been recorded globally, of which most have been in Europe since the virus first emerged in December.

More than 723,000 virus cases have been registered in 200 countries and territories of which the majority have been in Europe, the worst-hit continent so far.

https://www.geo.tv/latest/279904-chinese-strain-of-coronavirus-different-than-pakistani-one-dr-atta
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">BREAKING: We’re launching a test that can detect COVID-19 in as little as 5 minutes—bringing rapid testing to the frontlines. <a href="https://t.co/LqnRpPpqMM">https://t.co/LqnRpPpqMM</a> <a href="https://t.co/W8jyN2az8G">pic.twitter.com/W8jyN2az8G</a></p>— Abbott (@AbbottNews) <a href="https://twitter.com/AbbottNews/status/1243680163054915584?ref_src=twsrc%5Etfw">March 27, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

That will be great.

Meet the Pakistani who assisted making the '5-minute COVID-19 testing kit'

A Pakistani was part of the team of software engineers who helped develop a portable test that can tell if someone has COVID-19 in as little as five minutes.

Abbott Laboratories said the US Food and Drug Administration (FDA) had given it emergency authorisation to begin making the test available to healthcare providers as early as next week.
The test, which is the size of a small toaster and uses molecular technology, also shows negative results within 13 minutes, the company said in a statement.

Jameel Sheikh, a Pakistani software engineer hailing from Sindh’s Larkana district who graduated from Karachi’s NED Engineering University before moving to the United States, was among the engineer who received the first batch of the kit for testing.

The pharmaceutical giant in its statement said that they are ramping up production to deliver 50,000 COVID-19 tests per day by next month for the US healthcare system.

“Testing remains a crucial step in controlling the novel COVID-19 pandemic. Continuing to supply healthcare providers with new technologies to help curb the spread of infection is a top priority for public health officials and healthcare providers,” the statement added.

According to the report, Sheikh is also an active member of World Sindhi Congress and Sindhi Association of North America.

The novel coronavirus emerged in the central China city of Wuhan towards the end of last year and proliferated to almost the whole world within a couple of months.

It’s not the virulence or fatality, but the infectivity of the new virus – also known as SARS-CoV-2 – that has set off global frenzy. The COVID-19 respiratory illness caused by this mysterious contagion has so far infected more than half a million people in 202 countries and territories of the world – more than 30,000 of them have died and counting.

https://tribune.com.pk/story/2187672/1/
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">FDA authorizes use of new two-minute test kit for coronavirus <a href="https://t.co/bvFl6xAvtI">https://t.co/bvFl6xAvtI</a> <a href="https://t.co/e5SpETqvbb">pic.twitter.com/e5SpETqvbb</a></p>— Reuters (@Reuters) <a href="https://twitter.com/Reuters/status/1245004393721856007?ref_src=twsrc%5Etfw">March 31, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
Great great news. IT Will help in detecting maximum people and that too earlier in their disease..
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">FDA authorizes use of new two-minute test kit for coronavirus <a href="https://t.co/bvFl6xAvtI">https://t.co/bvFl6xAvtI</a> <a href="https://t.co/e5SpETqvbb">pic.twitter.com/e5SpETqvbb</a></p>— Reuters (@Reuters) <a href="https://twitter.com/Reuters/status/1245004393721856007?ref_src=twsrc%5Etfw">March 31, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

Hope those are not defective items
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">VIDEO: Thailand launches a COVID-19 strip test, aiming to circumvent the standard test with a fast-track alternative which can provide results within 10-15 minutes. The test's main goal is to help expand the capacity of virus testing options within Thailand <a href="https://t.co/IB4Oj4hDgp">pic.twitter.com/IB4Oj4hDgp</a></p>— AFP news agency (@AFP) <a href="https://twitter.com/AFP/status/1245282253912936448?ref_src=twsrc%5Etfw">April 1, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
<blockquote class="twitter-tweet"><p lang="en" dir="ltr">Treatment news! 5 critically ill COVID patients (on ventilators) received antibody-rich plasma from 5 other patients who had recovered from COVID. <br><br>Results: 3 discharged; 2 in stable condition!<br><br>Now 1 of my recovering patients wants to donate his plasma!<a href="https://t.co/UJqjNwqPps">https://t.co/UJqjNwqPps</a></p>— Faheem Younus, MD (@FaheemYounus) <a href="https://twitter.com/FaheemYounus/status/1245547129831067649?ref_src=twsrc%5Etfw">April 2, 2020</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">Our PB 560 Ventilator is being open sourced. <a href="https://twitter.com/Medtronic?ref_src=twsrc%5Etfw">@Medtronic</a> design and specs will be available to be manufactured by anyone. An unprecedented human challenge requires an unprecedented response. <a href="https://twitter.com/hashtag/COVID19?src=hash&ref_src=twsrc%5Etfw">#COVID19</a> <a href="https://t.co/c4XBRMtLhv">https://t.co/c4XBRMtLhv</a></p>— Omar Ishrak (@MedtronicCEO) <a href="https://twitter.com/MedtronicCEO/status/1244600905858797568?ref_src=twsrc%5Etfw">March 30, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
The White House is expected to advise Americans in coronavirus hotspots to wear cloth masks or scarves in public to help stop the virus spread.

President Donald Trump said such an advisory would not be mandatory.

Residents of New York, the epicentre of the US outbreak, have already been urged to cover their faces in public.

Top health official Dr Anthony Fauci has said he believed all states should issue stay-at-home orders, as the US death toll passed 6,000.

"I don't understand why that's not happening," Dr Fauci told CNN late on Thursday. "If you look at what's going on in this country, I just don't understand why we're not doing that."

"You've got to put your foot on the accelerator to bring that number down," he added, referring to infection and death rates.

The comments from Dr Fauci, who heads the National Institute of Allergy and Infectious Diseases, appeared to contradict those of Mr Trump, who has consistently dismissed the notion of a nationwide lockdown.

"It's awfully tough to say, 'close it down.' We have to have a little bit of flexibility," Mr Trump said on Wednesday.

New York City is the worst-hit area, with 1,562 deaths in the pandemic, Johns Hopkins University reports.

Both the US Centers for Disease Control (CDC) and the World Health Organization (WHO) are reassessing their guidance on face masks, as experts race to find ways to fight the highly contagious virus.

Covid-19 is carried in airborne droplets from people coughing or sneezing, but there is some dispute over how far people should distance themselves from each other, and whether masks are useful when used by the public.

The WHO advises that ordinary face masks are only effective if combined with careful hand-washing and social-distancing, and so far it does not recommend them generally for healthy people.

However, more and more health experts now say there are benefits. They argue that the public use of masks can primarily help by preventing asymptomatic patients - people who have been infected with Covid-19 but are not aware, and not displaying any symptoms - from unknowingly spreading the virus to others.

Masks may also help lower the risk of individuals catching the virus through the droplets from another person's sneeze or a cough - and people can be taught how put masks on and take them off correctly, they argue.

On Thursday New York mayor Bill de Blasio urged all New Yorkers to cover their faces when outside and near others, but not to use surgical masks, which are in short supply.

"It could be a scarf. It could be something you create yourself at home. It could be a bandana," he said.

"It doesn't need to be a professional surgical mask. In fact, we don't want you to use the kind of masks that our first responders need.

Meanwhile, residents in Laredo, Texas will now face a $1,000 (£816) fine if they fail to cover their noses and mouths while outside, after city officials issued an emergency ordinance to its approximately 250,000 residents this week.

Dr Deborah Birx, one of President Trump's coronavirus advisers, expressed caution about general mask-wearing. "We don't want people to get an artificial sense of protection," she said. "They're an additive."

There is also disagreement among experts over the benefits of using cloth masks. European advisers say reusable cloth masks are not recommended and may even increase the chance of infection.

https://www.bbc.com/news/world-us-canada-52148534
 
Coronavirus: Tunisia deploys police robot on lockdown patrol

A police robot has been deployed to patrol areas of Tunisia's capital, Tunis, to ensure that people are observing a coronavirus lockdown.

If it spies anyone walking in the largely deserted streets, it approaches them and asks why they are out.

They must then show their ID and other papers to the robot's camera, so officers controlling it can check them.

This is the second week of a nationwide lockdown to contain the virus, which has killed 14 people.

Everyone must stay in their homes, but people are allowed out for medical reasons or to purchase necessities.

The North African nation currently has 436 people being treated for Covid-19, the respiratory illness caused by coronavirus.

How does the robot work?

It is not clear how many of the Tunisian-built surveillance robots, called PGuards, have been deployed by the interior ministry.

The manufacturer, Enova Robotics, told the BBC it was a confidential matter. It also refused to reveal the price tag.

A four-wheeled PGuard has a thermal-imaging camera and Lidar (light detection and ranging) technology, which works like radar but uses light instead of radio waves.

The interior ministry posted a video on Facebook about its futuristic mission to impose the restrictions not long after the lockdown started.

Some welcomed the move, while others said the robot "moved too slowly" to be effective.

But several videos have since appeared on social media showing people being stopped by a PGuard. In one a man, who is asked if he knows there is an ongoing lockdown, explains that he wants to buy cigarettes.

The robot replies: "OK buy your tobacco, but be quick and go home."

Before coronavirus swept the world, Enova's clients were largely private firms, its chief sales officer Radouhane Ben Farhat told me.

The firm, which has its headquarters in the coastal city of Sousse, also produces a "healthcare" robot, he said.

It can give a preliminary visual diagnosis and use its sensors to measure certain things - and one will be soon be working at a hospital in Tunis.

This would help minimise physical contact between medics and patients with Covid-19, Mr Farhat said.

Robotic technology and artificial intelligence (AI) are increasingly being used during these exceptional times as has been seen in China, which has used disinfecting robots and thermal camera-equipped drones amongst other gadgets to fight coronavirus.

https://www.bbc.co.uk/news/world-africa-52148639
 
Coronavirus may spread through normal breathing: US scientists

The new coronavirus might spread through the air via normal breathing and speaking, a top United States scientist said Friday as the government was poised to recommend the use of face masks for everyone.

Anthony Fauci, head of infectious diseases at the National Institutes of Health, told Fox News the guidance on masks would be changed "because of some recent information that the virus can actually be spread even when people just speak, as opposed to coughing and sneezing."

As it stands, the official advice is that only sick people need to cover their faces, as well as those caring for them at home.

Fauci's comments come after the National Academy of Sciences (NAS) sent a letter to the White House on April 1 that summarised recent research on the subject.

It said that though the research isn't yet conclusive, "the results of available studies are consistent with aerosolisation of virus from normal breathing."

Until now, US health agencies have said that the primary pathway of transmission is respiratory droplets, about one millimeter in diameter, expelled by sick people when they sneeze or cough.

These quickly fall to the ground around a meter away.

But if the virus can be suspended in the ultrafine mist we expel when we exhale, in other words an aerosol, it becomes much harder to prevent its spread, which in turn is an argument in favor of everyone covering their faces.

The aerosol debate
A recent NIH funded study published in the New England Journal of Medicine found that the SARS-CoV-2 virus could become an aerosol and remain airborne for up to three hours.

This triggered a debate even as critics said the findings were overblown because the team behind the study used a medical device called a nebuliser to deliberately create a viral mist and argued this would not occur naturally.

The NAS letter pointed to preliminary research by the University of Nebraska Medical Center that found the genetic code of the SARS-CoV-2 virus, its RNA, were found in hard to reach areas of patients' isolation rooms.

The NAS scientists also pointed to two other studies – both not yet peer reviewed – from Hong Kong and from mainland China.

The Hong Kong researchers collected viral samples from patients with the coronavirus and other viral respiratory illnesses, and gave some of the patients face masks.

The masks reduced the detection of both droplets and aerosols for coronavirus patients.

The Chinese paper on the other hand raised concerns that personal protective gear used by health care workers could itself be a source of airborne virus.

The team studied hospitals in Wuhan and found that there were two major areas where the virus was aerosolised: the bathrooms of patients, and rooms where medical staff removed their protective gear.

This may be because doffing protective gear causes the particles to get re-suspended in the air. Even if these particles are not of breathable size, they could settle on people's hands and bodies, the NAS panel said.

So far, the World Health Organisation (WHO) has been more cautious on the airborne threat.

In an analysis published on March 29, it wrote that aerosol transmission was only known to occur during particular medical treatments that required assisted breathing.

On the recent preliminary research, such as the University of Nebraska's paper, the WHO cautioned that the detection of the virus' genetic code in patient's rooms did not necessarily amount to viable amounts of the pathogen that could be transmitted onward.
https://www.dawn.com/news/1546177/coronavirus-may-spread-through-normal-breathing-us-scientists
 
Dr Shahid Masood, the history of BCG vaccine and its effects on the coronavirus

Do you agree with Dr. Shahid Masood or it is too early to predict? Explaining the reason why there are less deaths in India, Pakistan, Bangladesh etc.

<iframe width="560" height="315" src="https://www.youtube.com/embed/ZcaR1M8l5Wc" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
 
Human gene variants may offer resistance against Covid-19, Dow research suggests

A study by the Dow University of Health Sciences in Karachi has revealed that certain variants of a human gene may offer resistance against the novel coronavirus, called SARS-CoV-2, which has infected more than 1.5 million people globally and killed tens of thousands.

The SARS-CoV-2 is a strain of the coronavirus, which also caused the severe acute respiratory syndrome and Middle East respiratory syndrome. The new strain of the coronavirus, however, has proven to be the most difficult to deal with, due to its fast spread.

The research by Dow University, which has been reviewed by peers and published in the Journal of Medical Virology, says that two variants of the ACE2 (angiotensin I converting enzyme 2) gene — that has been established as the functional receptor for the novel coronavirus — may make a person more resistant to the infection.

The research team, led by Dow College of Biotechnology's Vice Principal Dr Mushtaq Hussain, observed the binding of different variants of the ACE2 gene with the new coronavirus and noted that most of them "showed similar binding affinity for SARS-CoV-2 spike protein as observed in the complex structure of wild type ACE2 and SARS-CoV-2 spike protein".

However, the research team said that two allelic variations of the ACE2 gene, identified as S19P and E329G, "showed noticeable variations in their intermolecular interactions" with the virus.

The researchers studied mutations in ACE2 after examining over a thousand samples of the gene obtained by genomic data mining. The molecular structures of the variant genes were created by homology modelling. According to Dr Hussain, genome data had been extracted from individuals residing in China, Latin America and some European countries.

It should be noted that considering the number of countries that have been hit by Covid-19, the number of variants studied is quite low.

It is also pertinent to mention that the research does not suggest that the person who possesses the variants would become immune to the virus. They would not, however, experience severe symptoms and may only need to be isolated for two weeks.

Dow University's Vice Chancellor Muhammad Saeed Quraishy congratulated the research team on their findings and expressed hope that studies like these would enable the world in finding a way to curb the virus.

https://www.dawn.com/news/1547823/h...stance-against-covid-19-dow-research-suggests
 
Virus appears to strike men, overweight people harder

Paris (AFP) - In the emergency rooms of virus hotspots around the world, medical staff are seeing a greater number of men than women suffering severe symptoms of COVID-19, with obesity emerging as another potentially aggravating factor. But experts are still unsure why.

What first began to appear as a pattern in China, where the virus emerged at the end of last year, has echoed through hospitals in Europe and the United States as the pandemic spreads.

"More men than women have serious problems, and patients who are overweight or have previous health problems are at higher risk," said Derek Hill, Professor of Medical Imaging Science at University College London.

Early statistics from Britain's independent Intensive Care National Audit and Research Centre on people treated in intensive care for the virus confirm this phenomenon: 73 percent are men and 73.4 percent are classed as overweight.

According to preliminary data of outcomes for those patients who had either recovered or died of COVID-19 in the period before April 3, obese patients were also less likely to recover after receiving critical care.

Some 42.4 percent of people with a body mass index (BMI) over 30 were able to go home after successful treatment, compared with 56.4 percent of patients with a BMI of less than 25.

French emergency rooms have seen "a very large proportion of overweight or obese patients," ICU doctor Matthieu Schmidt at the Pitie-Salpetriere hospital in Paris told broadcaster France 2, adding that "three quarters" of all patients were men.

In New York there is a similar picture emerging.

"I'm in the emergency room, and it's remarkable -- I'd estimate that 80 percent of the patients being brought in are men," Hani Sbitany, a reconstructive surgeon at Mount Sinai Health System who has been treating COVID-19 patients in Brooklyn.

"It's four out of five patients," he told the New York Times.

But why are so many men affected? Just months after the new coronavirus appeared, experts say it is too early to tell for certain.

The high incidence of men presenting with more severe symptoms is for now "an observation", said Jean-Francois Delfraissy, who leads the coronavirus science council advising the French government.

While he said there was "no clear explanation", he raised the theory that men had a higher frequency of multiple pathologies.

"I am very humble vis-a-vis this virus. I did not know it three and a half months ago. There are lots of question marks," he told France Info radio.

- Biology and behaviour -

Some experts say that it might not be men's vulnerability that makes the difference, but women's immune strength.

"Innate immunity is better in women, especially before menopause," said Pierre Delobel, head of the infectious diseases department at the Toulouse University Hospital

James Gill, a locum doctor and honorary clinical lecturer at Warwick Medical School, said one idea was that women "may have a more aggressive immune system, meaning a greater resilience to infections".

Another, he said was that "the assumption that simply men don't look after their bodies as well, with higher levels of smoking, alcohol use, obesity", adding that the answer may be a mixture of both biology and environmental factors.

Obesity adds to health risks in general, with an increase in the incidence of diabetes and hypertension -- both identified as aggravating factors of COVID-19 in Italian and Chinese studies, along with age and to a lesser extent heart cardiovascular and cerebrovascular disease.

This raises a particular concern for the United States, where some 42 percent of adults are obese, according to the US Centers for Disease Control and Prevention, which has warned people with a BMI over 40 could be at higher risk of severe illness from COVID-19.

"We are worried about our American friends. They will probably have more problems because of obesity," said Delfraissy.
https://news.yahoo.com/virus-appears-strike-men-overweight-people-harder-135422006.html
 
Do you agree with Dr. Shahid Masood or it is too early to predict? Explaining the reason why there are less deaths in India, Pakistan, Bangladesh etc.

<iframe width="560" height="315" src="https://www.youtube.com/embed/ZcaR1M8l5Wc" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>

Everyone is trying to be hero, but the timing of this discussion and talking it over TV is wrong and dangerous in Pakistan at this point This is an interesting theory but nothing is proven yet, lets hope its true. But spreading this theory in Pakistan at this point will only serve to spread the false or unproven sense of security and could backfire by lowering the guard by general public to prevent covid 19 infection. Until the pandemic is over or this theory is conformed no one should talk about it, serves no purpose.

I said the same on Pakistan TV in an interview two weeks ago when asked about this.
 
Everyone is trying to be hero, but the timing of this discussion and talking it over TV is wrong and dangerous in Pakistan at this point This is an interesting theory but nothing is proven yet, lets hope its true. But spreading this theory in Pakistan at this point will only serve to spread the false or unproven sense of security and could backfire by lowering the guard by general public to prevent covid 19 infection. Until the pandemic is over or this theory is conformed no one should talk about it, serves no purpose.

I said the same on Pakistan TV in an interview two weeks ago when asked about this.

This is very dangerous. Shouldn't happen in tv.
 
Some doctors moving away from ventilators for virus patients

As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can.

This is because some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.Some doctors moving away from ventilators for virus patients
As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can.

This is because some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.
 
Some doctors moving away from ventilators for virus patients

As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can.

This is because some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.Some doctors moving away from ventilators for virus patients
As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can.

This is because some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.

If you're trying to fly a plane and don;t know how to, you can kill the passengers rather than taking them to their destination. I'm sure these "some doctors" don;t know how to manage a patient on ventilator. God forbid if any of their family member needs a ventilator they will be the first one to ask for one.
 
South Korea Reports Recovered Coronavirus Patients Testing Positive Again

South Korean officials on Friday reported 91 patients thought cleared of the new coronavirus had tested positive again.

Jeong Eun-kyeong, director of the Korea Centers for Disease Control and Prevention (KCDC), told a briefing that the virus may have been "reactivated" rather than the patients being re-infected.

South Korean health officials said it remains unclear what is behind the trend, with epidemiological investigations still under way.

The prospect of people being re-infected with the virus is of international concern, as many countries are hoping that infected populations will develop sufficient immunity to prevent a resurgence of the pandemic.

The South Korean figure had risen from 51 such cases on Monday.

Nearly 7,000 South Koreans have been reported as recovered from COVID-19, the disease caused by the new coronavirus.

"The number will only increase, 91 is just the beginning now," said Kim Woo-joo, professor of infectious diseases at Korea University Guro Hospital.

The KCDC's Jeong raised the possibility that rather than patients being re-infected, the virus may have been "reactivated".

Kim also said patients had likely "relapsed" rather than been re-infected.

False test results could also be at fault, other experts said, or remnants of the virus could still be in patients' systems but not be infectious or of danger to the host or others.

"There are different interpretations and many variables," said Jung Ki-suck, professor of pulmonary medicine at Hallym University Sacred Heart Hospital.

"The government needs to come up with responses for each of these variables".

South Korea on Friday reported 27 new cases, its lowest after daily cases peaked at more than 900 in late February, according to KCDC, adding the total stood at 10,450 cases.

The death toll rose by four to 208, it said.

The city of Daegu, which endured the first large coronavirus outbreak outside of China, reported zero new cases for the first time since late February.

With at least 6,807 confirmed cases, Daegu accounts for more than half of all South Korea's total infections.

The spread of infections at a church in Daegu drove a spike in cases in South Korea beginning in late February.

The outbreak initially pushed the tally of confirmed cases much higher than anywhere else outside of China, before the country used widespread testing and social distancing measures to bring the numbers down.

https://www.haaretz.com/science-and...rus-patients-testing-positive-again-1.8756671
 
If you're trying to fly a plane and don;t know how to, you can kill the passengers rather than taking them to their destination. I'm sure these "some doctors" don;t know how to manage a patient on ventilator. God forbid if any of their family member needs a ventilator they will be the first one to ask for one.

We don't have enough trained Pulmonologists and Support Team. A Pulmonologist supervising the ICU is not a concept here in Pakistan.

So this is Hypoxic Hypoxia.
Not Histotoxic Hypoxia by any means, Right ?
 
<blockquote class="twitter-tweet" data-cards="hidden" data-lang="en"><p lang="en" dir="ltr">An infectious disease expert at Stanford University said transmission of the coronavirus can still happen in hot or cold weather <a href="https://t.co/Q0YbUEAjOZ">pic.twitter.com/Q0YbUEAjOZ</a></p>— Reuters (@Reuters) <a href="https://twitter.com/Reuters/status/1250068793889611777?ref_src=twsrc%5Etfw">April 14, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
We don't have enough trained Pulmonologists and Support Team. A Pulmonologist supervising the ICU is not a concept here in Pakistan.

So this is Hypoxic Hypoxia.
Not Histotoxic Hypoxia by any means, Right ?

You don;t need a pulmonologist , this disease is not restricted to lungs only. You need an intensivit ( Critical care specialist ). Managing ventilator is part of training of an intensivist, and much more.
 
The coronavirus pandemic may have been started by stray dogs eating bat meat, according to a study.

Professor Xuhua Xia, from the University of Ottawa's biology department, has suggested that stray dogs are the most likely intermediate host for the transmission of Sars-CoV-2 into humans.

According to the study, the ancestor of the new coronavirus and its nearest relative - a bat coronavirus - infected the intestines of dogs. They then evolved before moving to humans.

Humans and mammals can fight viruses through an antiviral protein which stops the infection multiplying. Meanwhile, regions of DNA - CpG dinucleotides - tell the immune system to attack the virus.

But single-strand coronaviruses can avoid the body's natural defences by reducing the CpG.

Prof Xia analysed betacoronavirus genomes and found that Sars-CoV-2 and its closest relative - a bat coronavirus - have the lowest amount of CpG.

Only genomes from canine coronaviruses have similar genomic values, the study says.

The cellular receptor for Sars-CoV-2 is "pervasively expressed in the human digestive system", the study says, adding: "This is consistent with the interpretation that the low CpG in Sars-CoV-2 was acquired by the ancestor of Sars-CoV-2 evolving in mammalian digestive systems.

"The interpretation is further corroborated by a recent report that a high proportion of Covid-19 patients also suffer from digestive discomfort.

"In fact, 48.5% presented with digestive symptoms as their chief complaint."

Prof Xia said the results suggested "the importance of monitoring Sars-like coronaviruses in feral dogs in the fight against Sars-CoV-2".

But Professor James Wood, head of the department of Veterinary Medicine and researcher in infection dynamics at the University of Cambridge, was not convinced.

He said: "There is far too much inference and far too little direct data. I do not see anything in this paper to support this supposition and am concerned that this paper has been published in this journal.

"I do not believe that any dog owners should be concerned as a result of this work."

Nearly two million people worldwide have been infected by the virus.

The findings are published online in the journal Molecular Biology and Evolution.

https://news.sky.com/story/coronavi...demic-study-says-11973364?dcmp=snt-sf-twitter
 
The commander of the Islamic Revolution Guard Corps has unveiled a handheld device that he said could identify people infected with the coronavirus within 100m (330ft), Tasnim news agency reports.

"The basis of this device is to create a magnetic field based on a bipolar virus inside the device, so its antenna can focus on any place within a 100m diameter that is infected by the virus, and identify the infected place in five seconds," Maj-Gen Hossein Salami was quoted as saying.

He added that its accuracy was "80%”, but provided no evidence.

Experts say the only reliable way to test for Covid-19 currently is by taking a swab of the nose or throat, which is sent off to a lab to look for signs of the virus’s genetic material.
 
Australia to detect coronavirus spread by testing raw sewage

SYDNEY (Reuters) - Australian researchers said on Thursday they expect to roll out wide testing of raw sewage for the presence of coronavirus within weeks to help pinpoint communities at risk, after a successful regional pilot.

The trial in Queensland by national science agency CSIRO and the University of Queensland will be used to develop a surveillance system researchers said will help officials when they start to wind back restrictions on public movement.

The new project utilises an existing system under which crime agencies monitor wastewater, covering about 57% of the population, to detect the presence of illicit drugs in Australian cities.

In the Queensland trial, scientists were able to detect a gene fragment of the novel coronavirus in untreated sewage from two wastewater treatment plants.

Used on a wider scale, sewage sampling would be able to detect the approximate number of people infected in a geographic area without testing every individual, the CSIRO said. Officials are currently testing thousands of Australians daily using conventional tests.

The CSIRO’s land and water science director, Paul Bertsch, said the project would help governments ease nationwide curbs on public movement by highlighting problem areas, allowing many Australians to get out of their homes.

“I see it as an important surveillance tool for easing restrictions,” Bertsch told Reuters. “As governments ease up, they will need to keep monitoring and respond to outbreaks.”

Australia has closed restaurants, bars and stores deemed “non-essential” while using the threat of fines and even prison to stop public gatherings of more than two people in a bid to slow transmission of the flu-like illness.

The strict measures have helped slow growth in the daily rate of new infections drastically to low single digits, from about 25% several weeks ago, for a total of about 6,500 infections, including 63 deaths.

Prime Minister Scott Morrison said on Thursday those restrictions would stay in place for at least another month, although officials have begun talking about how to start a wind-back.

Health Minister Greg Hunt said a wider detection regime including sewage sampling would help show whether there were COVID-19 cases in the broader community.

University of Queensland professor Kevin Thomas, one of the researchers on the sewage trial, said it was likely national testing would be achieved “in a matter of weeks”.

Remote and regional communities, where it is more difficult for health authorities to conduct traditional swab tests, could particularly stand to benefit, he said.

Bertsch said sewage sampling could be conducted daily, and while the first tests would be taken at wastewater treatment plants, there was potential to take sampling “further up the pipe” to a suburb level by going down neighbourhood man-holes.

Bertsch said Chinese data showed the virus could be detected in faeces within three days, quicker than many cases were being detected with conventional tests.

https://www.reuters.com/article/us-...us-spread-by-testing-raw-sewage-idUSKCN21Y0RI
 
FBI official says foreign hackers have targeted COVID-19 research

A senior cybersecurity official with the Federal Bureau of Investigation said on Thursday that foreign government hackers have broken into companies conducting research into treatments for COVID-19, the sometimes fatal respiratory illness caused by the coronavirus.

FBI Deputy Assistant Director Tonya Ugoretz told participants in an online panel discussion hosted by the Aspen Institute that the bureau had recently seen state-backed hackers poking around a series of healthcare and research institutions.

“We certainly have seen reconnaissance activity, and some intrusions, into some of those institutions, especially those that have publicly identified themselves as working on COVID-related research,” she said.

Ugoretz said it made sense for institutions working on promising treatments or a potential vaccine to tout their work publicly. However, she said, “The sad flipside is that it kind of makes them a mark for other nation-states that are interested in gleaning details about what exactly they’re doing and maybe even stealing proprietary information that those institutions have.”

Ugoretz said that state-backed hackers had often targeted biopharmaceutical industry but said “it’s certainly heightened during this crisis.” She did not name specific countries.

Ugoretz did not identify the targeted companies. The FBI did not immediately return an email seeking comment.

https://www.reuters.com/article/us-...have-targeted-covid-19-research-idUSKBN21Y3GL
 
FBI official says foreign hackers have targeted COVID-19 research

A senior cybersecurity official with the Federal Bureau of Investigation said on Thursday that foreign government hackers have broken into companies conducting research into treatments for COVID-19, the respiratory illness caused by the coronavirus.
 
Smokers 14 times more likely to contract coronavirus

Smokers are 14 times more likely to contract coronavirus compared with those who do not, the head of a Turkish anti-addiction group told Anadolu Agency.

Professor Mucahit Ozturk, president of anti-addiction group Turkish Green Crescent, on Thursday urged those who smoke to quit to protect themselves from the contagion.

"Using tobacco and tobacco products increases the risk of catching the coronavirus, therefore, avoiding all addictive substances plays an important role in protecting ourselves against the virus," Ozturk said.

Ozturk underscored smoking weakens the immune system and has negative impacts on coronavirus treatment.

"A weak immune system poses a threat to your health since it delays the treatment process and makes treatment difficult during the epidemic, even if you occasionally use addictive substances," he said.

"Smoking can cause damage to the lungs and block the cough reflex so viruses and bacteria could stick to the airways and lungs, which could lead to serious infections."

The World Health Organization (WHO) also said smokers are likely to be more vulnerable to the virus as fingers are in contact with the lips, which increases the possibility of hand-to-mouth transmission.

According to research by Chinese doctors, cited by the European Centre for Disease Control and Prevention, acute smokers were more at risk of dying than elderly people.

"The human body is programmed to recover from the moment you stop smoking," Ozturk said.

After first appearing in Wuhan, China last December, COVID-19 has spread to at least 185 countries and territories.

More than two million cases have been reported worldwide, with the death toll at more than 137,000 and 517,000 recoveries, according to data compiled by US-based Johns Hopkins University.

https://www.aljazeera.com/news/2020/04/smokers-14-times-contract-coronavirus-200416071258252.html
 
The World Health Organization has just cautioned against placing too much stock in antibody tests - they're the tests to see if someone has already had the virus.

The first problem with antibody tests is there aren’t any that work, but even if they did there are potential issues.

There are no guarantees that if you have antibodies against the coronavirus that you are completely immune.

And even if your antibodies do protect you from becoming sick, then you may be able to harbour the virus in your body and pass it to others.

There will be many challenges before immunity passports, allowing you to resume life as normal if you pass an antibody test, will be practical.

This is the problem with a virus that has only been around for a couple of months – there is still too much we do not understand.

However, the main appeal of antibody testing is to find out how many people have really been infected with the virus.
 
FBI official says foreign hackers have targeted COVID-19 research

A senior cybersecurity official with the Federal Bureau of Investigation said on Thursday that foreign government hackers have broken into companies conducting research into treatments for COVID-19, the respiratory illness caused by the coronavirus.

Absolutely sickening.

What kind of human trash hacks this type of research?
 
There is no evidence that people who have recovered from coronavirus have immunity to the disease, the World Health Organisation (WHO) has said.

The UK government has bought 3.5 million serology tests - which measure levels of antibodies in blood plasma.

But senior WHO epidemiologists have warned that there is no proof that such antibody tests can show if someone who has been infected with COVID-19 cannot be infected again.

Many of the tests being developed are pinprick blood tests similar to instant HIV tests and measure for raised levels of the antibodies that the body uses to fight the virus.

Speaking at a news conference in Geneva, Dr Maria van Kerkhove said: "There are a lot of countries that are suggesting using rapid diagnostic serological tests to be able to capture what they think will be a measure of immunity.

"Right now, we have no evidence that the use of a serological test can show that an individual has immunity or is protected from reinfection."

She added: "These antibody tests will be able to measure that level of seroprevalence - that level of antibodies - but that does not mean that somebody with antibodies means that they are immune."

Dr van Kerkhove said it was "a good thing" that so many tests are being developed, but said they will need to be validated "so that we know what they say they attempt to measure they are actually measuring".

Her colleague Dr Michael Ryan said the antibody tests also raised ethical questions.

He said: "There are serious ethical issues around the use of such an approach and we need to address it very carefully, we also need to look at the length of protection that antibodies might give.

"You might have someone who believes they are seropositive (have been infected) and protected in a situation where they may be exposed and in fact they are susceptible to the disease."

He added that the tests had to be used as part of a coherent public health policy.

The WHO is due to issue updated guidance on the issue this weekend.

https://news.sky.com/story/coronavi...19-survivors-have-immunity-who-warns-11975011
 
<div style="width: 100%; height: 0px; position: relative; padding-bottom: 50%;"><iframe src="https://streamable.com/s/kl65t1/ohswaw" frameborder="0" width="100%" height="100%" allowfullscreen style="width: 100%; height: 100%; position: absolute;"></iframe></div>

UAE doing something new!
 
BBC teams are fact-checking some of the most popular fake and misleading coronavirus stories on social media. Jack Goodman brings together what's been debunked this week by BBC Monitoring, Trending and Reality Check.

False claims about the BCG vaccine
WhatsApp messages claiming the BCG vaccine prevents coronavirus infection are inaccurate.

The Bacille Calmette-Guérin jab has been given to children around the world to fight off tuberculosis, and was widespread in secondary schools in the UK until 2005.

It's still given in the UK when a child or adult might be at risk of coming into contact with tuberculosis.

It's still common in many countries, such as Syria, where rumours are spreading that people shouldn't worry about coronavirus if they've had the BCG jab because it gives them immunity.

A WhatsApp message in Arabic says that if you have the circular scar from the jab on your arm, you could be "75% protected" against Covid-19.

However, the World Health Organization says there is no evidence that the BCG protects people from Covid-19 infection.

The health body says two clinical trials are under way involving BCG, and when completed, their findings will be evaluated by the WHO.

Despite the lack of medical evidence, global search for the term "BCG" has spiked, according to Google.

The WHO is concerned that increased demand for the vaccine means there'll be less of it available to inoculate children against tuberculosis.

Similar fears have also been voiced by suppliers in Japan, reporting a surge in demand for the BCG vaccine.


Iran's dodgy detector

The head of Iran's Revolutionary Guard Corps (IRGC) unveiled a hand-held device this week which he claimed could identify people infected with coronavirus - and even contaminated surfaces - up to a distance of 100m and within five seconds.

The Physics Society of Iran described the announcement as "pseudoscience", "unbelievable" and on a par with "sci-fi tales".

The device bears an uncanny resemblance to fake bomb detector tools sold by British fraudsters more than a decade ago, all of which claimed to use the same "electrostatic magnetic ion attraction".

The bogus bomb detectors were in fact empty cases with an aerial which swings according to the user's unconscious hand movements. They ended up in conflict zones and were used by a number of governments around the world.

This latest device has an almost identical case and antenna.

Even the packaging, which can be seen in a clip of it being unveiled on Iranian state TV, looks similar.

The virus wasn't created in a lab

A video published by the Epoch Times, that contains claims that the coronavirus was created in a laboratory, has been marked false on Facebook where it has been watched almost 70 million times.

The opening feels like a slick and dramatic Netflix documentary - there's a flash and crack of a lightning bolt followed by ominous music.

The hour-long video includes a theory about a lab in Wuhan creating the virus and leaking it, due to poor security.

The BBC's science editor, Paul Rincon, says "there's currently no evidence that any research institute in Wuhan was the source of Sars-CoV-2" (which causes Covid-19).

Scientific analysis of the evidence shows the virus came from animals, and was not man-made.

A peer-reviewed study in March found no evidence the coronavirus had been engineered, stating that "it is improbable that SARS-CoV-2 emerged through laboratory manipulation."

The video also refers to a study from Indian researchers that claimed to find four new sequences had been inserted into the new coronavirus, which were also present in HIV, to suggest the virus is man-made.

But that paper, never peer-reviewed, was withdrawn by its authors. And the genetic information that had matched is common in many other organisms.

"Those sequences are so short that they match with many different organisms, not just HIV. It doesn't mean they're related," says Dr Jeremy Rossman, a virologist at the University of Kent.

Epoch Times, based in New York City, was started by Chinese-Americans affiliated with a religious group called Falun Gong.

The site spent heavily on pro-Donald Trump Facebook adverts last year, reported NBC News.

But in August Facebook banned it from taking out more ads for violating its policies.

More Bill Gates rumours

This week Bill Gates' criticism of Donald Trump's decision to halt funding for the WHO sparked a new wave of misinformation and speculation about Mr Gates.

It followed familiar themes, such as criticising Mr Gates' support for vaccines.

Multiple posts resurfaced on Facebook claiming that a research institute funded by the Bill and Melinda Gates Foundation owns the patent on the coronavirus causing the current pandemic.

These claims are all totally unsubstantiated. The suggestion that Covid-19 is a human creation sponsored by Bill Gates is false.


The Covid pandemic is not fake

The coronavirus pandemic is "fake" and "truly a farce" is the claim of a holistic doctor interviewed by Canal Monteria, a Colombian news channel. The video went up last month but has now been viewed 18 million times and is still being shared on Facebook, which is why we're addressing it now.

The claim is clearly false - coronavirus does exist.

The man in the video goes unchallenged and says that present theories on viruses are all wrong, and recommends a video on YouTube that denies the existence of HIV to prove his point.

He doesn't at any point explain why people are getting ill.

https://www.bbc.co.uk/news/52310194
 
As a pandemic grips the world, a person could be forgiven if they had forgotten about another threat to humanity's way of life - the rise of robots.

For better or worse the robots are going to replace many humans in their jobs, analysts say, and the coronavirus outbreak is speeding up the process.

"People usually say they want a human element to their interactions but Covid-19 has changed that," says Martin Ford, a futurist who has written about the ways robots will be integrated into the economy in the coming decades.

"[Covid-19] is going to change consumer preference and really open up new opportunities for automation."

Companies large and small are expanding how they use robots to increase social distancing and reduce the number of staff that have to physically come to work. Robots are also being used to perform roles workers cannot do at home.

Walmart, America's biggest retailer, is using robots to scrub its floors.

Robots in South Korea have been used to measure temperatures and distribute hand sanitiser.

With health experts warning some social distancing measures may need to be in place through 2021, robot workers may be in greater demand.

Companies that make cleaning and sanitising products have seen demand soar.

UVD Robots, the Danish manufacture of ultraviolet-light-disinfection robots, shipped hundreds of its machines to hospitals in China and Europe.

Groceries and restaurants offering takeaway are using these machines more too.

Experts say as more businesses re-open we can expect to see further adoption of this technology - you may see robots cleaning your schools or offices.

"Customers now care more about their safety and the safety and health of workers," says Blake Morgan, author of The Customer of the Future.

"Moves towards automation can keep them all healthier and customers will reward companies that do this."

There are still limitations. Ms Morgan points out that automated checkouts at groceries should reduce human interactions but because many systems don't work well or break easily customers avoid them and go to human cashiers instead.

Help with social distancing
Food service is another area where the use of robots is likely to increase because of health concerns.

Fast-food chains like McDonald's have been testing robots as cooks and servers.

In warehouses, like those operated by Amazon and Walmart, robots were already used to improve efficiency. The Covid-19 outbreak has both companies looking to increase the use of robots for sorting, shipping and packing.

This may reduce the number of complaints by warehouse workers who say they cannot social-distance from their colleagues under the current conditions. But, according to technology experts, it would put some of them out of work.

Once a company has invested in replacing a worker with a robot it's unlikely the firm will ever rehire for that role. Robots are more expensive to create and integrate into businesses but once they are up and running, robots are typically cheaper than human workers.

According to the futurist Martin Ford, using robots in the post Covid-19 world also presents some marketing advantages.

"People will prefer to go to a place that has fewer workers and more machines because they feel they can lower overall risk," he explains

AI that's as real as humans
What about service roles where a person is needed to offer a lesson or guideline?

Artificial intelligence is being developed that can replace school tutors, fitness trainers and financial advisers.

Big tech companies are expanding the use of artificial intelligence. Both Facebook and Google are relying on AI to remove more inappropriate posts since the companies' human content moderators can't review certain things from home.

Robot sceptics had believed humans would have an edge in those jobs. That could be changing as lockdowns have made humans more comfortable with the idea of connecting remotely. The instructor or adviser on the screen doesn't need to be a real person, it just needs to think and act like one.

A 2017 report by global consultants McKinsey predicted a third of workers in the US would be replaced by automation and robots by 2030. But events like pandemics have the potential to change all the timelines and experts say it's really up to humans to decide how they want to integrate this technology in the world.

https://www.bbc.co.uk/news/technology-52340651
 
Novartis, US drug regulator agree to malaria drug trial against Covid-19

Novartis has won the go ahead from the US Food and Drug Administration (FDA) to conduct a randomised trial of malaria drug hydroxychloroquine against Covid-19, the Swiss drugmaker said, according to Reuters.

The decades-old generic medicine got FDA emergency use authorisation this month for its unapproved use for the coronavirus, but so far there is no scientific proof it works.

Novartis plans to start recruiting 440 patients for its trial at more than a dozen US sites. Results will be reported as soon as possible, the company added.
 
Novartis, US drug regulator agree to malaria drug trial against Covid-19

Novartis has won the go ahead from the US Food and Drug Administration (FDA) to conduct a randomised trial of malaria drug hydroxychloroquine against Covid-19, the Swiss drugmaker said, according to Reuters.

The decades-old generic medicine got FDA emergency use authorisation this month for its unapproved use for the coronavirus, but so far there is no scientific proof it works.

Novartis plans to start recruiting 440 patients for its trial at more than a dozen US sites. Results will be reported as soon as possible, the company added.

Isn't this old news. As far as I am aware there are many hydroxychloroquine trials going on.
 
Air pollution linked to raised Covid-19 death risk

High levels of air pollution could raise the risk of dying from Covid-19, two studies suggest.

Dr Maria Neira, of the World Health Organization (WHO), told BBC News countries with high pollution levels, many in Latin America, Africa and Asia, should ramp up their preparations.

Those with underlying pollution-related conditions have developed severe Covid-19 in countries with high levels.

But medical professionals say it is too early to prove a direct relationship.

"We will be doing a map of most polluted cities based on our database to support national authorities in these regions so that they can prepare their epidemic response plan accordingly," Dr Neira said.

A US study suggests Covid-19 death rates rise by about 15% in areas with even a small increase in fine-particle pollution levels in the years before the pandemic.

"Patterns in Covid-19 death rates generally mimic patterns in both high population density and high [particulate matter] PM2.5 exposure areas," the Harvard University report says.

These particles, one-30th the diameter of a human hair, have previously been linked to health issues including respiratory infections and lung cancer.

The Harvard study has not yet been peer reviewed but Ludwig Maximilian University of Munich chair of epidemiology Air pollution linked to raised Covid-19 death riskProf Annette Peters told BBC News its findings "are in line with earlier reports on hospitalisation and mortality due to pneumonia".

"It is one of the first studies substantiating our suspicion and the hypothesis that severity of the Covid-19 infection may be augmented by particulate matter air pollution," she said.

Report author Prof Francesca Dominici said: "We hope it will help stop the air quality from getting worse, particularly when we are hearing about authorities trying to relax pollution rules amid this pandemic."

Another study, at the University of Siena, in Italy, and Arhus University, in Denmark, suggests a possible link between high levels of air pollution and Covid-19 deaths in northern Italy.

The Lombardy and Emilia Romagna regions had death rates of about 12%, compared with 4.5% in the rest of Italy.

The study, published in Science Direct, says: "The high level of pollution in northern Italy should be considered an additional co-factor of the high level of lethality recorded in that area."

Population, age, differing health systems, and a variation in prevention policies across regions should also be taken into account.

Meanwhile, in the Philippines, Cesar Bugaoisan, of the Association for Respiratory Care Practitioners, said: "In our preliminary data, almost all of the dead individuals in the country due to coronavirus had pre-existing conditions, most of them linked to air pollution."

Air pollution already kills about seven million people every year, the WHO says.

And more than 90% of the world's population live in places where air pollution exceeds its guideline limits, mostly in poor countries.

Many of the affected countries are in South Asia, the Middle East, sub-Saharan and North Africa, according to a World Bank report last year.

Cities in Chile, Brazil, Mexico and Peru also have dangerous levels of air pollution, according to several WHO and United Nations reports.

But the World Air Quality Report 2019 suggests India has the most cities with high air pollution levels.

India has recorded 521 Covid-19 deaths so far.

Dr S K Chhabra, pulmonary department head at Primus Super Speciality Hospital, in Delhi, said: "If we see a significant rise in the spread of the virus, people with underlying conditions because of air pollution will definitely be the worst affected."

And Public Health Foundation India president Prof Srinath Reddy said: "If air pollution has already damaged the airways and lung tissue, there is reduced reserve to cope with the onslaught of coronavirus."

But Dr Rajni Kant Srivastava, of the Indian Council for Medical Research, said: "There is not enough evidence and we have also not carried out any such study."

The 2002 severe acute respiratory syndrome (Sars) outbreak, caused by a different strain of coronavirus, infected more than 8,000 people, in 26 countries, and killed almost 800.

And a 2003 University of California, Los Angeles study suggested people from areas of high air pollution were more than twice as likely to die from the disease.

https://www.bbc.com/news/health-52351290
 
We know that older people are more vulnerable to covid-19, but another major risk factor has emerged: being male.

The first signs of a sex difference in covid-19 severity emerged from hospital records in Wuhan shortly after the city locked down. On 30 January, a team at Shanghai Jiaotong University School of Medicine published a report on 99 covid-19 patients who were admitted to Jinyintan Wuhan hospital between 1 January and 20 January. They found that among those admitted, men outnumbered women by more than two to one.

There has also been a sex difference among deaths. Mortality data from 21 hospitals in Wuhan between 21 and 30 January, for example, revealed that 75 per cent of those who died were men.

Since then, larger studies from other countries have backed up these earlier findings. In England, Wales and Northern Ireland, for example, around 70 per cent of critically ill patients admitted to intensive care have been male, and a higher proportion of men than women have died. A study of more than 4000 covid-19 patients in New York City hospitals found that 62 per cent were male.

The difference doesn’t appear to be caused by differential rates of infection: the New York study, for example, found that equal numbers of men and women catch the virus. But men are more likely to progress to severe illness and death.

Smoking and ACE2
Two previous emerging coronavirus diseases, SARS and MERS, have also been found to disproportionately affect men. But this isn’t the case with respiratory infections generally. The report on England, Wales and Northern Ireland also looked at sex data on patients critically ill with viral pneumonia between 2017 and 2019, mostly due to influenza. There was an excess of men in this cohort too, but the ratio was less stark: 54 deaths for every 46 female deaths.

One possible reason for the sex difference is smoking. In China, over half of men smoke but only 5 per cent of women do. Tobacco smoke appears to cause lung cells to produce more of a surface protein called ACE2, which the virus exploits to infect cells. This may mean that smoking makes cells more susceptible to the virus.

However, according to an analysis by Hua Linda Cai at the University of California, Los Angeles, this hypothesis isn’t supported by the data. Current smokers only make up about 12.5 per cent of people severely ill with covid-19 in China, she says, which is much lower than the proportion of smokers in the general population.

Another possibility is that men – older men in particular – are in generally worse health than women. They tend to have higher rates of obesity, high blood pressure, diabetes, cancer and lung and cardiovascular disease, all of which have been linked to covid-19 severity. When the authors of the New York study factored these conditions into their analysis, they found that sex was no longer one of the main risk factors for severe covid-19.

Immune differences
A possibly related idea is that women may naturally have stronger immune defences. “There are substantial differences in the immune system between males and females and these have significant impact on outcome from a wide range of infectious diseases,” says immunologist Philip Goulder at the University of Oxford.

One key difference is that women have two X chromosomes per cell whereas men have one. “A number of critical immune genes are located on the X chromosome,” says Goulder, in particular the gene for a protein called TLR7, which detects single-stranded RNA viruses like the coronavirus. “As a result, this protein is expressed at twice the dose on many immune cells in females compared to males, and the immune response to coronavirus is therefore amplified in females,” he says.

While one X chromosome is usually inactivated in each female cell, the TLR7 gene somehow escapes this in some immune cells, meaning women produce more of the protein.

There is also some evidence that female sex hormones such as oestrogen and progesterone boost the immune system, but this hasn’t been specifically investigated in covid-19 yet.

Another possibility is that men are simply less hygienic. They are less likely to comply with basic sanitation measures such as hand washing, says Kunihiro Matsushita of Johns Hopkins University.

A study of sex differences in China found that men with covid-19 in hospital were also more likely to be carrying other viruses, including flu, and bacteria, and it is possible that this may increase the severity of covid-19 symptoms.

Read more: https://www.newscientist.com/articl...symptoms-and-die-from-covid-19/#ixzz6KAy5WYQF
 
Controversial given the high risk of deaths, a coronavirus strategy discarded by the U.K. is being touted as the solution for poor but young countries like India.

Herd immunity, which allows a majority of the population to gain resistance to the virus by becoming infected and then recovering, could result in less economic devastation and human suffering than restrictive lockdowns designed to stop its spread, according to a growing group of experts.

“No country can afford a prolonged period of lockdowns, and least of all a country like India,” said Jayaprakash Muliyil, a prominent Indian epidemiologist. “You may be able to reach a point of herd immunity without infection really catching up with the elderly. And when the herd immunity reaches a sufficient number the outbreak will stop, and the elderly are also safe.”

A team of researchers at Princeton University and the Center for Disease Dynamics, Economics and Policy, a public health advocacy group based in New Delhi and Washington, has identified India as a place where this strategy could be successful because its disproportionately young population would face less risk of hospitalization and death.

They said allowing the virus to be unleashed in a controlled way for the next seven months would give 60% of the country’s people immunity by November, and thus halt the disease.
Mortality could be limited as the virus spreads compared to European nations like Italy given that 93.5% of the Indian population is younger than 65, they said, though no death toll projections were released.

The radical proposal underscores the challenges that poorer developing countries -- including nations like Indonesia and some in sub-Saharan Africa -- face in curbing the epidemic using the lockdown measures that have been adopted by advanced economies.

The impossibility of social distancing in crowded living conditions like in many cities and villages in India, the lack of testing kits to detect infections and the human suffering that occurs in lockdowns suggests a different path may be needed in these places.

The Journey to Herd Immunity

*According to a study published April 7, 2020

To do this, the Princeton and CDDEP team recommends lifting India’s strict lockdown -- which has been extended to May 3 -- and letting most of the population younger than 60 return to normal life, though social distancing still would be encouraged, masks would be required and large gatherings would be banned. The reopening would be accompanied by an effort to test as many people as possible and isolate confirmed and suspected cases.

People over 60 would essentially have to remain under lockdown until herd immunity is achieved, and be prioritized for testing and treatment if they fell sick.

The government of Prime Minister Narendra Modi has given no indication it plans to adopt such a strategy.

Yet India’s government has laid out criteria that effectively rations coronavirus tests, limiting them to the very sick or most at risk. Critics who suspect the disease has dispersed much more widely than the official numbers suggest say the government’s restrictive criteria amounts to allowing the disease to spread.

“In some sense, you are saying, we will let them get infected and recover, and take care only of those who are sick,” said T. Sundararaman, the New Delhi-based global coordinator of the People’s Health Movement, a public health group. “That’s the policy, that’s what it amounts to.”

The government has maintained its testing criteria gives an accurate tally of India’s number of cases, and says the disease is not spreading untracked in the community. Nevertheless, as India has ramped up testing, it is finding more cases each day, bringing the nationwide tally to 20,080, with 645 deaths, as of April 21.

But while questions remain as to the extent and severity of India’s outbreak, the costs of the lockdown are clear. Local governments have had to set up camps to house 1.25 million migrants who left cities when they lost work, while food camps feed 7.5 million daily wage earners also rendered destitute by the lockdown. There are already signs these stopgap measures are starting to fray.

India Workers Paid $4 a Day Are Trapped Between Hunger and Virus

“We’re dealing with a trade-off against starvation, hunger, all this other stuff,” said Ramanan Laxminarayan, the director of the CDDEP and a Princeton researcher. By allowing the coronavirus to spread in a controlled way, “undoubtedly there will be deaths, but it will be much smaller this way, and it opens us up for business by November,” he said.

But the strategy has already proved controversial internationally. The U.K. adopted and then abandoned it early in the pandemic after projections showed its health care system would be overwhelmed by the resulting hospitalizations. That brief dalliance is still being blamed for the British government’s slow response in testing for the virus.

Risky Strategy
Even in a country like India with a young population, the concept has inherent risks. Allowing people to become infected will inevitably bring many more patients to hospitals. The researchers say India will have to urgently expand critical care and isolation-bed capacity to ensure that multiple waves of patients don’t become casualties before herd immunity is reached.

Another risk is that India’s worst-in the-world air pollution and high rates of hypertension and diabetes have compromised young people’s health, meaning that mortality from the virus could be higher than expected. People may let their guards down and fail to follow social distancing guidelines.

India Imposes Nationwide Lockdown To Contain Spread Of The Coronavirus Pandemic
A policeman sends a motorist back after he tried to cross a barricade during a lockdown in New Delhi on April 20.Photographer: Yawar Nazir/Getty Images
“I would worry that it would relax concerns of younger individuals, who still remain at substantial risk themselves,” Jason Andrews, an assistant professor of medicine at Stanford University, said in an email. “The messaging in particular may lead younger people to perceive themselves as at lower risk than they are, and to fail to understand their potential role in transmission.”

And given the novel coronavirus only made its debut in humans some time late last year, there’s still a lot that’s unknown. Immunity from the virus may be a more complex process than expected. One group of researchers estimated as much as 82% of the population would have to be infected before herd immunity is reached.

“My view is there are a number of questions about whether it can work,” said Marc Lipsitch, a professor of epidemiology at Harvard University’s T.H. Chan School of Public Health. “The main questions being how much immunity do we need in the population, and how much immunity does each person get as a result of infection.”

Then there’s also the question of whether it’s possible to wall off the higher-risk portion of the population in densely packed India, where multiple generations commonly live under one roof.

Ultimately, the researchers lobbying for the strategy argue that cultivating herd immunity may be the best of various bad options.

“I think eventually all countries will follow this Indian model,” Laxminarayan said. “Because otherwise we are going to be in lockdown on and off all the way through until June of next year.”

https://www.bloomberg.com/news/arti...trategy-could-actually-work-in-youthful-india
 
CORONAVIRUS STAYED IN WOMAN'S EYES FOR 20 DAYS

COVID-19 patient in Italy had the coronavirus lingering in her eye longer than in her nose, according to a case study.

The unnamed 65-year-old woman, Italy's first confirmed COVID-19 case, had travelled from Wuhan—the Chinese city which was the initial epicenter of the COVID-19 pandemic—to Italy on January 29, according to a research letter published in the Annals of Internal Medicine. She had arrived a day after her symptoms started.

The woman was taken to an isolation unit at Italy's Lazzaro Spallanzani National Institute for Infectious Diseases hospital in Rome. Her COVID-19 symptoms included a dry cough and a sore throat. She also had and an inflamed nasal cavity, and conjunctivitis in both her eyes—which is thought to be a COVID-19 symptom.

The woman later developed a fever of 100.4 degrees Fahrenheit and became nauseous. This happened on day four, but it was not clear if this was four days after her symptoms started or four days after she was admitted to hospital. A test confirmed she was infected with the coronavirus.

As her conjunctivitis wouldn't clear up, doctors decided to take a swab from her eye on her third day at the institution, and repeated this almost daily. The virus was present, but less concentrated, in her eye up to day 21.

"Conjunctivitis greatly improved at day 15 and apparently resolved at day 20," the team wrote.

But it returned on day 27, five days after the coronavirus was apparently no longer present in the woman's eye. Doctors found genetic material from the virus in eye swabs days after it was no longer present in samples from the nose. The team said their findings suggest that eye fluids from COVID-19 patients "may be a potential source of infection."

"These findings highlight the importance of control measures, such as avoiding touching the nose, mouth, and eyes and frequent hand washing."

In addition, it re-emphasizes that opticians should wear personal protective equipment while examining patients, because the mucous membrane of the eye may not only be an entry site for viruses, but also a means of transmission, they said. Next, researchers should try to pinpoint the eye cells which enable the coronavirus to replicate, the team suggested.

The authors noted that conjunctivitis "has been occasionally reported among COVID-19 symptoms, similar to infections caused by other human coronaviruses."

For instance, eye fluids were linked with a higher chance of healthcare workers catching the germ which causes SARS, also a member of the large coronavirus family of viruses, during that epidemic almost two decades ago.

Studies which have emerged from the ongoing COVID-19 pandemic cited by the authors also suggest the eye can carry the coronavirus.

Dr. Joshua Barocas, assistant professor of Medicine at the Boston University School of Medicine and infectious diseases physician at Boston Medical Center who did not work on the case study, previously explained to Newsweek that conjunctivitis is common in those with upper respiratory illnesses.

That's because our eyes, ears, nose, throat, and lungs are connected "so viruses (even common ones) can cause a constellation of symptoms in those locations," he said.

At the time, he said: "As of now, we do not know enough to say that it is completely consistent with COVID-19 infection though it could certainly be a symptom."

As shown by the Statista map below, Italy is among the countries with the highest known COVID-19 cases. According to Johns Hopkins University, more than 2.5 million cases have been confirmed worldwide, over 177,000 people have died, and over 686,000 are known to have survived.
https://www.newsweek.com/coronavirus-woman-eyes-1499368
 
German vaccine set for human testing

A possible vaccine for Covid-19, developed by German firm BioNTech and US drug giant Pfizer, has been given the green light for human testing.

The trial will begin with 200 healthy people, aged between 18 and 55, being given the vaccine.

"This is a good sign that the development of a vaccine in Germany is so progressed that we can start with the first studies," the country's health minister, Jens Spahn, said Wednesday. "At the same time the advice remains important that it will take months. This is an injection in the body. Safety first is the guideline for such a vaccine."

Only a handful of vaccine candidates have been approved for clinical testing on humans globally, and experts caution that it will take at least a year for a viable vaccine to be developed.

Scientists at the UK's Oxford University are starting human trials of a possible vaccine this week. Other clinical trials are taking place in the US and China.
 
Back
Top